The Kyodo News service has reported that Haruko Obokata has agreed to retract one of the two Nature papers on an easy method of making stem cells.
According to the report: Continue reading Obokata agrees to retract one of two STAP stem cell papers in Nature: Reports
Hiroaki Matsubara, a former Kyoto Prefectural University cardiology researcher who resigned last year following an investigation, has had another paper retracted, his ninth.
Here’s the notice from Arteriosclerosis, Thrombosis, and Vascular Biology: Continue reading Ninth retraction appears for cardiology researcher Matsubara
Shigeaki Kato, who resigned from the University of Tokyo in 2012 after being found to have inappropriately manipulated dozens of images, has two more retractions, both in Molecular Cell.
Here’s the notice for 2002’s “Nuclear Receptor Function Requires a TFTC-Type Histone Acetyl Transferase Complex:” Continue reading Shigeaki Kato up to 25 retractions
A group of researchers in Tokyo has lost their 2013 article in the Journal of Crystal Growth over commercial interests — which don’t appear to be their own.
We’ll explain.
The article, “Interactions between planar defects in bulk 3C-SiC,” came from a team consisting of a researcher at Keio University and scientists at two companies, HOYA Corporation, an optics firm, and SICOXS Corporation, which makes semiconductor wafers.
According to the abstract: Continue reading Crystal unclear? “Business decision” forces retraction of silicon paper
Over the past week, there have been a number of comments on PubPeer — a site of which we’re big fans — about a 2007 paper in Oncogene.
The comments suggested that the figures in the paper had problems. Some bands seemed to be duplicated, and one of the images looked very much like that of another paper.
Then, today, first author Eriko Suzuki left this comment: Continue reading Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship
I shot the sheriff
But I didn’t shoot no deputy, oh no! Oh!
I shot the sheriff
But I didn’t shoot no deputy, ooh, ooh, oo-ooh.
—Bob Marley
A group of pharmacologists in Japan has retracted their 2012 article in the International Journal of Pharmaceutics for plagiarism. But not, they note, for any other reason.
The article, “Suppression of efflux transporters in the intestines of endotoxin-treated rats,” came from researchers in the Department of Drug Absorption and Pharmacokinetics in the School of Pharmacy at Tokyo University of Pharmacy and Life Sciences. It has been cited once, according to Thomson Scientific’s Web of Knowledge.
Continue reading Integrity of data “undisputed” in paper pulled for plagiarism
Waseda University in Japan says it will be vetting every doctoral dissertation it awards its graduate-level students in Advanced Science & Engineering* for signs of plagiarism, according to a report in the Japan News, a site of the Yomiuri Shimbun. The paper reports that:
A complicated story involving Novartis’s valsartan (Diovan) has led to the retraction of two more papers, one cascading from the other.
Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.
Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”
Continue reading Novartis Diovan scandal claims two more papers
Japan’s RIKEN research center has found misconduct in work that led to two controversial Nature papers, purporting to show an easy way to create stem cells, that have been dogged by criticism for months.
Here’s an excerpt from today’s statement about “six items [RIKEN] has been investigating:”
Continue reading RIKEN finds two “instances of research misconduct” in STAP stem cell work
There have been a number of developments in the unraveling of two Nature studies out of the RIKEN Institute in Japan and Harvard purporting to show an easy way to create stem cells. There was an interim report of RIKEN’s investigation last Friday, and more details emerged this week.
And today, the Japan Times reported that last week, a correction of a 2011 paper by many of the same authors appeared in Tissue Engineering Part A. Here’s the correction notice, dated March 13: Continue reading Authors of controversial STAP stem cell study author correct 2011 paper